Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

July 8, 2020July 8, 2020

ProLynx Awarded NIH Grant to Develop Long-acting PTH Therapy

News

ProLynx has been awarded a small business innovation research grant from the National Institutes of Health (NIH) to develop its long-acting parathyroid hormone (PTH) therapy — known as PTH(1-34) — ... Read more

June 17, 2020June 17, 2020

Alizé Pharma 3 Rebrands as Amolyt Pharma, Plans AZP-3601 Trial

News

Alizé Pharma 3 is rebranding as Amolyt Pharma and plans to start clinical testing of a potential hypoparathyroidism treatment known as AZP-3601 later this year. “Our new name, Amolyt Pharma, ... Read more

May 6, 2020May 6, 2020

Calcific Tendonitis May Be Complication of Hypoparathyroidism

News

People with hypoparathyroidism may be at risk of having calcium crystals form in their tendons — a condition called calcific tendonitis — which can cause joint pain and inflammation, a ... Read more

April 15, 2020April 15, 2020

Supplement Need After Thyroid Cancer Surgery Linked to Poorer Life Quality

News

People needing to take vitamin D and calcium supplements due to very low levels soon after thyroid cancer surgery are likely to experience a decline in their quality of ... Read more

January 29, 2020January 29, 2020

High Rate of Calcium-alkali Syndrome Linked to Post-surgery Hypoparathyroidism, Study Suggests

News

People with hypoparathyroidism after surgical removal of the thyroid may develop calcium-alkali syndrome (CAS) — particularly if they are given high doses of vitamin D as a part of ... Read more

December 18, 2019December 18, 2019

Low PTH Levels May Lead to Greater Risk of Fractures in Hypoparathyroidism, Study Suggests

News

Lower levels of parathyroid hormone (PTH) in people with hypoparathyroidism may lead to decreased bone material strength and increase the risk of fractures, a new study reports. The study, ... Read more

November 20, 2019April 22, 2020

Phase 2 Trial of TransCon PTH to Speed Enrollment of Patients Affected by U.S. Recall of Natpara

News

A Phase 2 trial testing the experimental therapy TransCon PTH in adults with hypoparathyroidism is expanding to allow for faster enrollment of people previously treated with Natpara (parathyroid hormone, ... Read more

November 6, 2019November 6, 2019

PTH Levels 4 Hours After Thyroidectomy Is Best Predictor of Hypoparathyroidism, Study Suggests

News

Four hours after surgery is the best time to measure intact parathyroid hormone (iPTH) levels to predict the risk of hypoparathyroidism following thyroidectomy, a study in patients with papillary ... Read more

October 30, 2019April 22, 2020

Phase 2 Study of Treatment for Hypoparathyroidism, TransCon PTH, Starts to Enroll Adults

News

A Phase 2 trial evaluating the efficacy and safety of TransCon PTH — designed to restore parathyroid hormone (PTH) levels within 24 hours — in people with hypoparathyroidism is now enrolling adults ... Read more

July 31, 2019July 31, 2019

Fahr’s, Disease Marked by Calcium Deposits in Brain, Traced to Thyroid Surgery in Case Study

News

A case report of a person diagnosed with Fahr’s disease related to post-thyroidectomy hypoparathyroidism highlights the importance of doing regular screening, including brain scans and blood tests, after this ... Read more

Pin It on Pinterest